In Vivo CAR T: A New Route to Treating Autoimmune Disease
How targeted in vivo CAR T delivery could pave the way for autoimmune disease treatments
False
Advertisement
Related Content
Biopharma
Industry News
Development & Clinical
Phase III Success Marks Milestone for Personalized Cancer Vaccines
August 26, 2026
7 min read
Merck and Moderna report positive phase III results for intismeran in melanoma, as The Medicine Maker revisits how cancer vaccines work and the challenges still facing the field
Cell & Gene
Development & Clinical
Business & Trends
The Biggest Bottlenecks Holding Back Cell and Gene Therapy
August 24, 2026
9 min read
Members of the 2026 Power List argue that manufacturing, infrastructure, reimbursement, and investment now pose the greatest challenges
Small Molecules
Drug Discovery
Development & Clinical
Musings from The Power List: Daniel Vitt
August 20, 2026
6 min read
From multiple sclerosis to AI-driven discovery, Daniel Vitt reflects on the future of drug development
Cell & Gene
Development & Clinical
Interviews
The Road to Commercial-Scale iPSC Cell Therapy
August 19, 2026
5 min read
Can iPSC platforms deliver consistent, commercial-scale cell therapies for large patient populations?